KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Gains from Investment Securities (2016 - 2026)

Palvella Therapeutics has reported Gains from Investment Securities over the past 9 years, most recently at $307000.0 for Q4 2022.

  • Quarterly Gains from Investment Securities rose 923.33% to $307000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $91000.0 through Dec 2022, up 203.33% year-over-year, with the annual reading at $53000.0 for FY2023, 83.29% down from the prior year.
  • Gains from Investment Securities was $307000.0 for Q4 2022 at Palvella Therapeutics, up from -$2000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $1.3 million in Q4 2018 and troughed at -$764000.0 in Q4 2020.
  • The 5-year median for Gains from Investment Securities is -$11000.0 (2018), against an average of $68500.0.
  • Year-over-year, Gains from Investment Securities soared 3825.0% in 2019 and then crashed 580.5% in 2020.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.3 million in 2018, then plummeted by 87.53% to $159000.0 in 2019, then crashed by 580.5% to -$764000.0 in 2020, then surged by 103.93% to $30000.0 in 2021, then skyrocketed by 923.33% to $307000.0 in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Gains from Investment Securities are $307000.0 (Q4 2022), -$2000.0 (Q3 2022), and -$123000.0 (Q2 2022).